Browse Articles
Discover research articles across all indexed journals
Structural Evolution of Pt Nanoclusters Driven by CO Reactant Pressure and Catalyst Temperature
Nanographene‐Based van der Waals Organic Framework With Permanent Porosity
ABSTRACT Porous crystalline materials traditionally rely on robust coordination or covalent bonds. Herein, we report a new C 3 ‐symmetric molecular nanographene 1 containing three hexabenzocoronene (HBC) units that self‐organizes into a permanently porous framework exclusively using weak van der Waals interactions. Single‐crystal x‐ray diffraction results reveal a propeller geometry with C 3 symmetry, forming two‐dimensional honeycomb sheets parallel to the ab plane stabilized by π···π and C–H···π interactions. Nitrogen adsorption measurements at 77 K confirm a Type I(b) isotherm with a record‐breaking Brunauer–Emmett–Teller (BET) surface area of 1108 m 2 g −1 , the highest reported to date for purely organic van der Waals frameworks. Furthermore, compound 1 exhibits aggregation‐induced emission (AIE) and remarkable thermal stability up to 290° C. These results demonstrate that carefully designed nanographenes can achieve high structural predictability and robust porosity without the need for metal nodes or covalent linkages, opening new avenues for gas storage applications.
Impact of feature engineering on predicting non-contact football injuries
Circularly Polarized Metamaterial Cage for Homogeneous Signal‐to‐Noise Ratio Enhancement in Magnetic Resonance Imaging (Adv. Mater. 41/2026)
Recent Advances of Organic Room Temperature Phosphorescence for Biological Applications
ABSTRACT Organic room‐temperature phosphorescence (RTP) materials have attracted significant attention in the fields of organic light‐emitting diodes (OLEDs), secure data encryption, chemical sensing, bioimaging, and scintillation, driven by their superior triplet exciton utilization, large Stokes shifts, and long‐lived emission. However, traditional RTP systems are predominantly synthesized in the bulk state, resulting in inherent mechanical brittleness and poor aqueous dispersibility that impede their integration into complex biological environments. Developing high‐efficiency nanoscale organic phosphors that maintain intense triplet emission remains a formidable challenge. This review provides a comprehensive overview of prepared methods for phosphorescent nanoparticles (NPs) and elucidates molecular design strategies tailored to optimize RTP performance for biomedical frontiers. Specifically, we highlight their transformative potential in advanced bioimaging and photodynamic cancer therapy. Finally, we discuss current bottlenecks and offer a prospective outlook on future advancements, aiming to bridge the gap between fundamental molecular design and clinical translatability.
A comparative analysis between clinicopathologic correlates of mismatch repair status compared to combined mismatch repair status and microsatellite instability in Filipino patients with colorectal cancer.
124 Background: Colorectal cancer (CRC) management relies on molecular classification, specifically the Mismatch Repair (MMR) status and its corresponding phenotype, Microsatellite Instability (MSI). This molecular status is critical for determining eligibility for adjuvant chemotherapy in Stage II disease and, crucially, for immunotherapy. Given the high concordance between MMR protein expression (assessed by Immunohistochemistry, IHC) and MSI status (assessed by PCR), this study investigates whether MMR testing alone can reliably indicate MSI status and seeks to identify associated clinicopathologic characteristics, offering a potentially more cost-effective diagnostic strategy in a resource-constrained setting. Methods: This was a cross-sectional analytical study utilizing retrospective data from 136 adult patients with definitive CRC diagnosis at St. Luke’s Medical Center Quezon City from January 2021 to October 2025. Data on MMR status (IHC) was available for all patients, and a subset of 49 patients also had paired MSI status (PCR) results. Univariate and multivariable logistic regression analyses were used to determine the association of clinicopathologic factors (age, sex, tumor location, clinical stage, and histologic variant) with Deficient MMR (dMMR) status. The level of agreement between MMR and MSI was assessed using Cohen's Kappa statistic. Results: A high overall concordance rate of 87.76% was observed between MMR (IHC) and MSI (PCR) status in the paired subset. Analysis of the entire cohort revealed a 14.71% prevalence of dMMR. Multivariable logistic regression identified right-sided tumor location [Adjusted OR (AOR): 5.51; 95% CI: 1.07–28.49] and aggressive histologic variants (Mucinous/Signet Ring) [AOR: 18.7; 95% CI: 3.35–104.19] as significant independent predictors of dMMR status. While right-sided tumor location remained a significant predictor in the combined dMMR/MSI-H analysis, the association with histologic variants lost statistical significance in this smaller subset. Conclusions: MMR immunohistochemistry demonstrated high concordance with MSI testing, supporting its use as a reliable and cost-effective screening tool for molecular stratification in CRC. This study definitively establishes a high-risk phenotype in Filipino patients: right-sided tumors and aggressive histologic variants are strong independent predictors of Deficient MMR status. These findings provide essential local evidence to guide precision oncology, suggesting that accessible MMR IHC testing can be confidently integrated into routine practice to identify patients eligible for targeted therapies like immunotherapy, thereby optimizing resource allocation and improving clinical outcomes.
Digital literacy is associated with college students’ learning engagement via sequential mediation of self-efficacy and learning adaptability
Advancing Stem Cell Bioprinting to Bridge Engineered and Natural Tissue Constructs (Adv. Mater. 42/2026)
Aminotetrazole–Gold Nanocomplexes Shunt Electrons to Eradicate Bacteria Without ROS‐Induced Resistance
ABSTRACT Most bactericides directly or indirectly disrupt the electron transport chain (ETC)‐mediated energy metabolism to exert antibacterial effects. However, the consequent perturbation of electron transfer states (e.g., flux overload or blockade) leads to electron accumulation, which enhances reactive oxygen species (ROS) generation. High ROS concentrations kill bacteria, while sublethal levels induce DNA damage, thereby elevating antibiotic resistance risk. In this study, we found that shunting electrons at critical ETC nodes is able to disrupt bacterial energy metabolism, damaging bacteria without ROS generation. To leverage the ROS‐free mechanism for infection control, we synthesized 5‐aminotetrazole‐functionalized gold nanocomplexes (ATZ‐Au) that intercept electron transfer from electron donors to downstream carriers. This rapidly depletes reduced nicotinamide adenine dinucleotide (NADH), disrupts the proton motive force (PMF), impairs ATP synthesis, and blocks bacterial compensatory metabolic pathways, ultimately leading to lethal intracellular acidosis and metabolic collapse. This effect blocks the capture of electrons by oxygen, thereby preventing the generation of ROS. The ATZ‐Au efficiently eliminates pathogenic bacteria in complex infections, providing a promising strategy to address antibiotic resistance.
Impact of concurrent liquid and tissue NGS in advanced NSCLC: Real-world insights from an Indian single-centre study.
172 Background: Tissue NGS guides treatment in advanced NSCLC but is often limited by inadequate samples and delayed results. Upfront plasma cfDNA NGS may improve detection of actionable alterations and shorten time to therapy. We compared real-world clinical utility of upfront cfDNA versus routine tissue testing in advanced NSCLC (aNSCLC). Methods: In this real-world, single-center study, patients with aNSCLC underwent concurrent comprehensive genomic profiling using Guardant360 plasma cfDNA assay and Guardant360 tissue NGS between July 2022 and February 2026. The primary endpoint was detection of guideline-recommended Tier 1 actionable alterations by plasma NGS. Secondary analyses included concordance with matched tissue results, incremental diagnostic yield and turnaround time. Results: Among 76 patients, 73 (96%) yielded an informative cfDNA-NGS result. In the 35 patients who underwent paired tissue and plasma testing, Tier 1 actionable alterations were identified in 22 patients (63%). Importantly, plasma cfDNA-NGS uncovered 4 additional Tier 1 variants beyond tissue testing alone, resulting in a 23% relative increase in actionable detection (18 vs 22 patients). Median turnaround time was nearly two-fold shorter with plasma testing compared to tissue NGS (6 vs 11 days), enabling more rapid therapeutic decision-making. Matched targeted therapy was delivered to 19 of 22 patients (86%) with identified Tier 1 alterations. At a median follow-up of 549 days, median progression-free survival in the matched-treatment cohort was not reached, with 68% of patients remaining progression-free at the last observed timepoint reflecting durable clinical benefit associated with genomically guided therapy. Conclusions: In this real-world cohort of patients with advanced NSCLC, cfDNA-NGS enhanced detection of clinically actionable alterations with high concordance to tissue-based testing. Plasma testing identified additional targetable variants and significantly reduced turnaround time, enabling earlier treatment initiation without waiting for tissue genotyping results. These findings support concurrent plasma and tissue genomic profiling as a complementary and pragmatic approach to optimize precision oncology care in NSCLC.
Cation-Induced Interphasial Viscosity Variations on Gold Electrocatalysts in Nanoconfined Aqueous Electrolytes
Cytotoxicity and synergistic anticancer activity of Kigelia africana (Lam.) Benth. and Spathodea campanulata P. Beauv. polyherbal extracts
Photoinduced Structural Relaxation in Chiral Copper(l) Iodide Cluster Scintillators for Circularly Polarized Radioluminescence Imaging
ABSTRACT Circularly polarized luminescence offers untapped potential for enhancing x‐ray imaging resolution by suppressing optical crosstalk, yet its integration into high‐performance scintillators remains unexplored. Here we report a new class of chiral copper(I) halide scintillators, including enantiopure R‑/S‑3‑MLCuI (3‐ML represents 3‐methylmorpholine) circularly polarized scintillators and racemic Rac‑3‑MLCuI scintillators. Strategic enantiomer selection enables precise control over crystal symmetry—chiral P4 2 2 1 2 vs. centrosymmetric C2/c—dictating chiroptical activity. Combining TD‐DFT, in situ XAS, and ultrafast spectroscopy, we elucidate that emission originates from cluster‐centered self‐trapped excitons confined within discrete [Cu 4 I 4 ] cores, where pronounced excited‐state Cu─Cu contraction and Cu─I elongation induce strong exciton‐phonon coupling. Homochiral ligand environments impart persistent chiral imprinting, yielding |g lum | values up to 1.0 × 10 −2 . The materials exhibit record light yields (58 000 photons•MeV −1 ), exceptional x‐ray stability (>99% retention after 115 Gy), and ultra‐low detection limits (78.9 n Gy air •s −1 ). A flexible S‐3‐MLCuI@TPU film incorporating polarization‐gated imaging achieves 21.2 lp/mm resolution—significantly surpassing conventional scintillators by suppressing optical crosstalk. High‑fidelity x‑ray imaging of complex biological and electronic structures is demonstrated. This work provides a structure–property relationship that enables circularly polarized scintillation in chiral copper–iodide clusters, offering insights for further development of related systems.
Small Diameter Vascular Grafts Made in Minutes
ABSTRACT Vascular trauma demands rapid intervention to avert severe outcomes, yet current surgical treatments, including invasive autologous grafts and limited, potentially degrading synthetic prostheses, often fail to accommodate the requirements of variable vessel dimensions and shapes. To address these limitations, we present an additive manufacturing strategy for rapid, point‐of‐care fabrication of customizable vascular grafts using Focused Rotary Jet Spinning (FRJS). This technique enables the rapid, point‐of‐care fabrication of customizable small‐caliber vascular grafts within minutes. FRJS facilitates independent control over nanofiber alignment and centimeter‐scale vessel dimensions, yielding grafts with appropriate mechanical properties and flow characteristics. Four‐week in vivo evaluation in a rat femoral vasculature replacement model demonstrated sustained vascular patency and early tissue remodeling, supporting the potential for intraoperative generation of tailored vascular conduits.
Role of surgery in locally progressive gastrointestinal stromal tumors after imatinib therapy: A prospective multicenter real-world study.
121 Background: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumor of the gastrointestinal tract. The impact of surgical resection on progression-free survival (PFS) in patients with locally progressive GIST after imatinib therapy remains incompletely defined. This study aimed to explore the role of surgery in improving outcomes in this patient population. Methods: This prospective study, initiated in January 2018, included 110 patients from five tertiary centers in China: Zhongshan Hospital, Fudan University (n = 40); Fudan University Shanghai Cancer Center (n = 35); First Affiliated Hospital of Naval Medical University (n = 24); Renji Hospital, Shanghai Jiao Tong University (n = 9); Ruijin Hospital, Shanghai Jiao Tong University (n = 2). Patients were divided into Group A (n = 49, surgical resection) and Group B (n = 61, imatinib dose escalation or subsequent-line agents). Clinical and pathological features were recorded, including age, sex, primary tumor site, tumor size, mitotic index, and imatinib treatment duration. Continuous variables were summarized as median (range). PFS was estimated using the Kaplan-Meier method and compared by log-rank test. Results: Among the 110 patients, 75 (68.2%) were male and 35 (31.8%) were female, with a median age at diagnosis of 61 years (range, 19–84). Tumor characteristics included a median size of 55 mm (range, 25–144 mm) and a median mitotic count of 3/50 HPF (range, 1–7). The primary tumor sites were stomach (47%), intestine (35%), rectum (10%), and others (8%). All patients had received prior imatinib therapy and experienced local disease progression, with a median treatment duration of 36 months (range, 2–144). Among them, 49 patients underwent surgical resection (Group A), while 61 patients received imatinib dose escalation or subsequent-line agents (Group B). At 12 months, the estimated 1-year progression-free survival (PFS) was 94% in Group A versus 82% in Group B, showing a statistically significant difference (log-rank P = 0.04). Conclusions: Surgical resection improves progression-free survival in patients with locally progressive GISTs after imatinib therapy, supporting the role of surgery in selected patients even in the era of targeted therapy. Clinical trial information: ChiCTR2000029913 .
Integration of Fe Single Atoms to Improve Kinetics and Mass Transport in Oxygen Reduction Reaction for Zinc‐Air Batteries
ABSTRACT Simultaneous optimization of intrinsic activity and mass transport to enhance the oxygen reduction reaction (ORR) performance of zinc‐air battery (ZAB) cathodes is crucial yet remains a formidable challenge. In this study, we developed a cross‐scale synergy strategy to embed Fe−N 4 /Fe 3 C active microdomains into a 3D mesopore‐dominated carbon nanoflower framework (Fe SA /Fe 3 C NP @CNF). This approach effectively bridges the microscopic electronic modulation of active sites with the macroscopic regulation of the pore structure of the carbon framework, thus simultaneously improving intrinsic activity and mass transport. The resulting Fe SA /Fe 3 C NP @CNF electrocatalyst exhibits outstanding ORR performance with a half‐wave potential of 0.921 V versus RHE and superior stability. In ZABs, it delivers a high peak power density of 199.1 mW cm −2 and remarkable cycling stability over 500 h. In situ spectroelectrochemical measurements and theoretical calculations reveal that Fe 3 C modulates the electronic structure of Fe−N 4 sites by optimizing Fe 3d orbital occupancy and lowering the energy barrier for oxygen activation. Distribution of relaxation times, zero‐length column chromatography, bubble‐transport dynamics, and finite element simulations collectively demonstrate that the mesopore‐dominated nanoflower architecture promotes rapid oxygen transport and maximizes active‐site accessibility. This study establishes a versatile cross‐scale design principle for developing high‐performance ORR electrocatalysts in practical energy‐conversion devices.
Height-aware attention for industrial defect detection: co-designing imaging and deep networks for rubber–metal bushings
Ultrasound‐Assisted Zwitterion Grafting on NiO <sub>x</sub> for Suppressing Self‐Assembled Monolayer Migration in Perovskite Solar Cells
ABSTRACT Self‐assembled monolayers (SAMs) are widely used as hole‐selective materials in inverted perovskite solar cells (PSCs), yet their performance and stability are often limited by poor molecular ordering and interfacial incompatibility. Here, we present a novel ultrasonic chemical strategy to functionalize NiO x nanoparticles via anchoring the piperazine‐1,4‐bisethanesulfonic acid (PIPES) zwitterionic molecule. Ultrasonic cavitation generates hydroxyl radicals that oxidize Ni 2 + to Ni 3 + , enhancing the electrical conductivity and hole mobility of NiO x . The exposed sulfonate groups of PIPES further promote the uniform assembly and hydrogen bonding anchoring of the subsequent SAM layer [(4‐(9'‐phenyl‐9H,9'H‐[3,3'‐bicarbazole]‐9‐yl)butyl)phosphonic acid, 4PABCz]. This integrated NiO x +PIPES/4PABCz hole transport layer fosters stronger dipole formation and interfacial polarization, facilitating charge separation and transport. Consequently, the optimized devices achieve a champion power conversion efficiency (PCE) of 27.03% (with a certified steady‐state efficiency of 26.47%). Remarkably, the devices exhibit exceptional operational and thermal stability, retaining 88.2% of their initial PCE after 1000 h of continuous illumination at 85°C and 91.0% after 1200 h of thermal aging at 85°C. This work introduces a robust and effective NiO x modification strategy, providing profound insights into interfacial design for high‐performance, stable inverted PSCs.
Efficacy and Safety of Camrelizumab Plus Apatinib in Patients With Refractory Chordoma: A Phase II Clinical Trial
PURPOSE Limited efficacy of current treatments for chordoma calls for novel therapeutic options. Combination of immune checkpoint inhibitors and antiangiogenic drugs has altered the landscape of cancer treatment but has rarely been investigated in chordoma. METHODS An investigator-initiated, single-center, phase II trial was conducted on camrelizumab (a PD-1 inhibitor, 200 mg once every 2 weeks) plus apatinib (an antiangiogenic drug, 250 mg and 500 mg on alternate days, that is, 250 mg one day, 500 mg the next day, alternating) in patients with refractory chordoma for 4-week cycles. The primary end point was the objective response rate (ORR) per RECIST version 1.1. Secondary end points included ORR per Choi criteria, progression-free survival (PFS), overall survival, the disease control rate, median duration of response (mDoR), safety, and quality of life. The trial is registered with Chictr.org.cn (ChiCTR2100042938). RESULTS Of the 38 patients initially screened between September 2021 and October 2024, 33 were enrolled. Median follow-up duration was 20.8 months (IQR, 13.35-26.55). ORR was 24.2% (8/33 [95% CI, 11.1 to 42.3]) per RECIST 1.1 and 48.5% (16/33 [95% CI, 30.8 to 66.5]) per Choi criteria. The median PFS was 28.4 months (95% CI, 13.53 to 43.28). The mDoR was not reached per RECIST 1.1 and was 22.2 months (95% CI, 12.5 to not reached) per Choi criteria. CDKN2A copy-number deletion or homozygous deletion was found to associate with worse prognosis. The most common grade 3 or 4 treatment-related adverse events included increased aspartate aminotransferase (13 [39.4%]) and increased alanine aminotransferase (11 [33.3%]). No treatment-related deaths occurred. CONCLUSION Combination of camrelizumab and apatinib offered encouraging efficacy with manageable toxicity in chordoma treatment. CDKN2A alterations are associated with worse prognosis and may prove to be a potential biomarker for treatment selection.